Global Aortic Aneurysm Repair Devices Market Overview:
Aortic Aneurysm Repair Devices is primarily used to treat infrarenal abdominal aortic aneurysm with or without associated iliac artery aneurysm. These advanced devices allow endovascular management of juxtarenal and potentially suprarenal aneurysms, and preservation of hypogastric flow when an adequate landing zone in the common iliac artery is not present. Since its first implementation in patients in 1991, endovascular aneurysm repair for abdominal aortic aneurysms has gained wide acceptance and availability. Increasing worldwide occurrences of abdominal aortic aneurysm fuel demand for devices In the market.
- Increasing approvals of novel devices by major regulatory bodies in the region
- Increasing collaborations and acquisition activities
- The high cost of the Aortic Aneurysm Repair Devices
- Technological advancements in medical devices
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are Medtronic (United States), Cardinal Health (United States), Cook Medical (United States), Fuji Systems (Japan), Braile Biomedica (Brazil), B.Braun (Germany), Boston Scientific (United States), Getinge Groups (Maquet) (Sweden), GRIKIN Advanced Materials (China) and HDH Medical (Israel). Additionally, following companies can also be profiled that are part of our coverage like Cardiatis (Belgium), Cytograft Tissue Engineering (United States), Endologix (United States) and Endospan (Israel). Analyst at AMA Research see United States Players to retain maximum share of Global Aortic Aneurysm Repair Devices market by 2025. Considering Market by Anatomy , the sub-segment i.e. Traditional Anatomy will boost the Aortic Aneurysm Repair Devices market. Considering Market by End User, the sub-segment i.e. Hospitals and Clinics will boost the Aortic Aneurysm Repair Devices market. Considering Market by By Site, the sub-segment i.e. Infrarenal AAA will boost the Aortic Aneurysm Repair Devices market.
In October 2020 Endologix presented ALTO Abdominal Stent Graft System in Europe and declared the main embed of its ALTO™ Abdominal Stent Graft, starting the European business arrival of the as of late CE Mark endorsed endograft. ALTO offers a profoundly separated endovascular treatment alternative for AAA patients and incorporates configuration includes that we accept will upgrade usability, improve intense results, and safeguard the drawn-out sturdiness related to understanding explicit anatomically adaptive fixing.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Aortic Aneurysm Repair Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Aortic Aneurysm Repair Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Aortic Aneurysm Repair Devices Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.